Petros Pharmaceuticals (PTPI) Institutional Ownership $0.42 -0.01 (-2.33%) (As of 07/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Petros Pharmaceuticals (NASDAQ:PTPI)CurrentInstitutional OwnershipPercentage12.34%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$20.30KNumber ofInstitutional Sellers(last 12 months)0 Get PTPI Insider Trade Alerts Want to know when executives and insiders are buying or selling Petros Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PTPI Institutional Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Petros Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/2/2023Bank of Montreal Can10,000$27K0.0%N/A0.478% 1/27/2022Emfo LLC10,000$33K0.0%-64.3%0.048% 11/12/2021NorthRock Partners LLC115,295$431K0.0%-47.4%1.173% 9/17/2021Virtu Financial LLC14,364$45K0.0%N/A0.146% 8/16/2021Shay Capital LLC238,764$747K0.1%-7.0%2.437% 8/13/2021Renaissance Technologies LLC54,887$172K0.0%-70.4%0.560% Get the Latest News and Ratings for PTPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/13/2021Geode Capital Management LLC23,725$74K0.0%+67.3%0.242% 8/13/2021Vanguard Group Inc.107,500$336K0.0%+21.2%1.097% 8/12/2021NorthRock Partners LLC219,188$686K0.1%-35.1%2.237% 8/10/2021CM Management LLC100,000$313K0.2%+122.2%1.021% 8/5/2021Platform Technology Partners44,000$138K0.1%N/A0.449% 5/21/2021Citadel Advisors LLC35,492$131K0.0%N/A0.362% 5/18/2021Citadel Advisors LLC35,492$131K0.0%N/A0.363% 5/13/2021Renaissance Technologies LLC185,545$692K0.0%+29.5%1.900% 5/12/2021Geode Capital Management LLC14,180$52K0.0%N/A0.145% 5/11/2021NorthRock Partners LLC337,531$1.26M0.1%-12.3%3.455% 5/7/2021BlackRock Inc.18,277$68K0.0%+35.1%0.187% 4/12/2021FNY Investment Advisers LLC20,000$73K0.0%N/A0.205% 3/4/2021 Neville Rodie & Shaw Inc.21,875$96K0.0%N/A0.224% 2/16/2021One68 Global Capital LLC24,883$109K0.2%N/A0.255% 2/11/2021Cannell Peter B & Co. Inc.25,484$112K0.0%N/A0.261% 2/10/2021Renaissance Technologies LLC143,247$630K0.0%N/A1.466% 2/8/2021NorthRock Partners LLC385,031$1.69M0.2%N/A3.942% 2/5/2021BlackRock Inc.13,531$59K0.0%N/A0.284% 2/5/2021CM Management LLC45,000$198K0.2%N/A0.946% 1/25/2021Acorn Financial Advisory Services Inc. ADV62,700$276K0.1%N/A1.318% (Data available from 1/1/2016 forward) PTPI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PTPI shares? During the previous two years, the following institutional investors and hedge funds held shares of Petros Pharmaceuticals shares: Bank of Montreal Can ($27K).Learn more on PTPI's institutional investors. What percentage of Petros Pharmaceuticals stock is owned by institutional investors? 12.34% of Petros Pharmaceuticals stock is owned by institutional investors. Learn more on PTPI's institutional investor holdings. Which institutional investors have been buying Petros Pharmaceuticals stock? The following institutional investors have purchased Petros Pharmaceuticals stock in the last 24 months: Bank of Montreal Can ($10K). How much institutional buying is happening at Petros Pharmaceuticals? Institutional investors have bought a total of 10,000 shares in the last 24 months. This purchase volume represents approximately $20.30K in transactions. Related Companies: Vaccinex Institutional Ownership Monopar Therapeutics Institutional Ownership Eterna Therapeutics Institutional Ownership NeuroSense Therapeutics Institutional Ownership RedHill Biopharma Institutional Ownership NuCana Institutional Ownership Tonix Pharmaceuticals Institutional Ownership Pieris Pharmaceuticals Institutional Ownership Agile Therapeutics Institutional Ownership Purple Biotech Institutional Ownership This page (NASDAQ:PTPI) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Petros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.